Diabetes is a chronic condition that makes it difficult to regulate blood sugar levels. For many people, the condition worsens with time, making it harder to control blood sugar levels. Semaglutide is one example of a GLP-1 receptor agonist that has given patients more control over blood sug
New Delhi [India], June 30: On the eve of National Doctor's Day, Metropolis Healthcare, India's leading diagnostic service provider, celebrates this special occasion by introducing Metrobot, a unique chatbot designed exclusively for doctors. Metrobot, which is designed to revolutionize docto
Researchers found loneliness is a greater risk factor for heart disease in diabetic patients than diet, exercise, smoking and depression. This research was published in the European Heart Journal, a journal of the European Society of Cardiology (ESC).
The first Skin Bank was inaugurated at the All India Institute Of Medical Sciences (AIIMS) Hospital on Thursday in New Delhi which will benefit burn patients.
Ahmedabad (Gujarat) [India], June 29: Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies with operations across the globe has launched TOFATAS - a DCGI-approved, Tofacitinib Ointment 2 per cent w/w for the treatment of mild to moderate Atopic Dermatitis (AD) in patie
New Delhi [India], June 28: The medical industry has grown leaps and bounds in terms of diagnosis and prevention of diseases particularly after the pandemic. IVD is significant in preventing, diagnosing, and treating ailments for relieving the stress on the healthcare industry and improving
According to a new study presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting, bariatric surgery, also known as weight-loss or metabolic surgery, was associated with a 42% lower risk of major adverse cardiovascular events (MACE) such as
Diabetes is a chronic condition that affects one's capacity to regulate blood sugar levels. Many patients' conditions worsen over time, making blood sugar levels more difficult to control. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have given patients greater con
A study led by researchers at the University of California San Diego School of Medicine looked into a possible new treatment option for patients with nonalcoholic steatohepatitis (NASH)-related fibrosis.
According to doctors at a cancer treatment facility in Herat Province, Western Afghanistan observes a 30 per cent increase in the number of patients seeking cancer treatment, Khaama Press reported.